Discovery and Optimization of ML417: A Potent and Highly Selective D3 Dopamine Receptor Agonist

被引:0
|
作者
Moritz, Amy E. [1 ]
Free, R. Benjamin [1 ]
Weiner, Warren [3 ]
Akano, Emannuel [1 ]
Bachani, Muzna [2 ]
Doyle, Trevor [1 ]
Southall, Noel [4 ]
Ferrer, Marc [4 ]
Javitch, Jonathan A. [5 ]
Steiner, Joseph [2 ]
Aube, Jeffrey [3 ]
Frankowski, Kevin [3 ]
Sibley, David R. [1 ]
机构
[1] NINDS, Mol Neuropharmacol, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA
[2] NINDS, Neurotherapeut Dev Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA
[3] Univ N Carolina, Chapel Hill, NC USA
[4] NIH, NCATS, Rockville, MD USA
[5] Columbia Univ, New York, NY USA
来源
FASEB JOURNAL | 2017年 / 31卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
663.5
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist
    Moritz, Amy E.
    Free, R. Benjamin
    Weiner, Warren S.
    Akano, Emmanuel O.
    Gandhi, Disha
    Abramyan, Ara
    Keck, Thomas M.
    Ferrer, Marc
    Hu, Xin
    Southall, Noel
    Steiner, Joseph
    Aube, Jeffrey
    Shi, Lei
    Frankowski, Kevin J.
    Sibley, David R.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (10) : 5526 - 5567
  • [2] In vivo Behavioral Characterization of ML417, a Novel D3 Dopamine Receptor-selective Agonist
    Akano, Emmanuel Oladele
    Moritz, Amy Elizabeth
    Preston, Michael Wayne
    Lobb, Collin Jethro
    Du Hoffmann, Johann Faustus
    Free, R. Benjamin
    Frankowski, Kevin J.
    Walters, Judith R.
    Sibley, David R.
    [J]. FASEB JOURNAL, 2018, 32 (01):
  • [3] Pharmacological actions of a novel and highly selective D3 dopamine receptor agonist, ML417, in a rodent model of Parkinson's disease
    Akano, Emmanuel O.
    Novikov, Nikolay
    Brazhnik, Elena
    Moritz, Amy E.
    Mccoy, Alex J.
    Free, R. B.
    Walters, Judith R.
    Sibley, David R.
    [J]. FASEB JOURNAL, 2022, 36
  • [4] Identification and optimization of a potent and highly selective D3 dopamine receptor agonist
    Amy E MORITZ
    R Benjamin FREE
    Warren WEINER
    Muzna BACHANI
    Trevor DOYLE
    Noel SOUTHALL
    Marc FERRER
    Jonathan A JAVITCH
    Joseph STEINER
    Ara ABRAMYAN
    Lei SHI
    Jeffrey AUBé
    Kevin FRANKOWSKI
    David R SIBLEY
    [J]. 中国药理学与毒理学杂志, 2017, 31 (10) : 950 - 951
  • [5] Identification of a Novel, Highly Potent D3 Dopamine Receptor-selective Agonist
    Sibley, David
    Moritz, Amy
    Free, R. Benjamin
    Conroy, Jennie
    Weiner, Warren
    Barnaeva, Elena
    Southall, Noel
    Ferrer, Marc
    Javitch, Jonathan
    Aube, Jeffrey
    Frankowski, Kevin
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S287 - S288
  • [6] CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist
    Chen, Jianyong
    Collins, Gregory T.
    Levant, Beth
    Woods, James
    Deschamps, Jeffrey R.
    Wang, Shaomeng
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (08): : 620 - 625
  • [7] An imprinted dopamine receptor for discovery of highly potent and selective D3 analogues with neuroprotective effects
    Naklua, Wanpen
    Mahesh, Krishna
    Aundorn, Phern
    Tanmanee, Niwan
    Aenukulpong, Kannatha
    Sutto, Salilla
    Chen, Yu Zong
    Chen, Shangying
    Suedee, Roongnapa
    [J]. PROCESS BIOCHEMISTRY, 2015, 50 (10) : 1537 - 1556
  • [8] Identification of highly potent and selective dopamine D3 ligands
    Chen, Jianyong
    Collins, Gregory T.
    Levant, Beth
    Woods, James
    Wang, Shaomeng
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [9] Interactive SAR studies:: Rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists
    Bettinetti, L
    Schlotter, K
    Hübner, H
    Gmeiner, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (21) : 4594 - 4597
  • [10] Scaffold repurposing of a serotonin 2C agonist led to the discovery of highly selective dopamine D3 antagonists
    Tan, Liang
    Cheng, Jianjun
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258